Clinical Trial Update: Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Ultrase MT12 in young children with cystic fibrosis and pancreatic insufficiency has completed, and results have been posted. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Insufficiency

Drugs mentioned

• Ultrase MT12

Snippet

Sponsor: Forest Laboratories | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2015-02-19